Idexx Laboratories (IDXX) | Stock Overview & Key Data

Idexx Laboratories, Inc. | Healthcare

US$511.99

0.50%

| Compare Stocks:

Idexx Laboratories vs Thermo Fisher Idexx Laboratories vs Danaher Idexx Laboratories vs Agilent Technologies Idexx Laboratories vs Iqvia Holdings Idexx Laboratories vs Mettler-Toledo Idexx Laboratories vs S&P 500 | Market

Idexx Laboratories Performance Comparison

Loading chart data...

Idexx Laboratories

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: US$505.00 High: US$513.33

on May 15, 2025

52 Week Range

Low: US$356.14 High: US$548.88

on April 9, 2025

on May 15, 2024

All-Time High: US$706.95 on July 26, 2021

Key Statistics

Market Cap i $41.0B

EPS i 10.84

P/E Ratio (TTM) i 46.99

Forward P/E i 42.59

P/B Ratio i 28.41

PEG Ratio i 42.59

Div. Yield i 0.00%

ROE i 59.33%

Beta i 1.525

Debt to Equity i 73.16

Financial Highlights

Profitability

Gross Margin i 62.44%

Operating Margin i 31.70%

Profit Margin i 22.76%

Returns and Earnings

Return on Assets (TTM) i 22.98%

Return on Equity (TTM) i 59.33%

EBITDA i $1.3B

Net Income (TTM) i $895.0M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Idexx Laboratories IDXX	40.97B Large-cap	4.45%	26.67%	13.97%	21.59%	25.18%	-5.83%	37.48%	73.64%
Thermo Fisher TMO	152.18B Large-cap	-1.42%	-8.18%	-22.59%	-21.08%	-22.51%	-32.01%	-27.10%	18.95%
Danaher DHR	136.66B Large-cap	3.01%	1.10%	-8.01%	-22.88%	-8.52%	-0.24%	-0.24%	-0.24%
Agilent Technologies A	32.05B Large-cap	3.30%	8.89%	-16.95%	-11.63%	-15.84%	-27.14%	-10.20%	32.23%
Iqvia Holdings IQV	24.53B Large-cap	-8.35%	-5.81%	-27.26%	-27.09%	-28.00%	-39.25%	-30.41%	-1.71%
Mettler-Toledo MTD	24.41B Large-cap	4.04%	9.51%	-9.98%	-2.84%	-6.12%	-24.84%	-7.60%	52.94%

Ownership & Short Interest

Insider Ownership i 0.67%

Institutional Ownership i 96.52%

Shares Short i 3M

Short Ratio i 2.62

Short % of Shares Outstanding i 4.66%

Average 10-Day Volume i 853K

Average 90-Day Volume i 1M

Idexx Laboratories Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Idexx Laboratories would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is IDXX's 52-week high and low?

In the last 52 weeks, Idexx Laboratories reached a high of US$548.88 (on May 15, 2024) and a low of US$356.14 (on April 9, 2025).

What is the market cap and P/E ratio for IDXX?

Curious about Idexx Laboratories's size and valuation? Its market capitalization stands at 40.97B. When it comes to valuation, the P/E ratio (trailing twelve months) is 46.99, and the forward P/E (looking ahead) is 42.59.

Does IDXX pay dividends? If so, what's the yield?

As for dividends, Idexx Laboratories isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Idexx Laboratories's main competitors or similar companies to consider before investing?

When looking at Idexx Laboratories, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Thermo Fisher TMO	152.18B	Healthcare	Diagnostics & Research	-32.01%	-27.10%
Danaher DHR	136.66B	Healthcare	Diagnostics & Research	-0.24%	-0.24%
Agilent Technologies A	32.05B	Healthcare	Diagnostics & Research	-27.14%	-10.20%
Iqvia Holdings IQV	24.53B	Healthcare	Diagnostics & Research	-39.25%	-30.41%
Mettler-Toledo MTD	24.41B	Healthcare	Diagnostics & Research	-24.84%	-7.60%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Idexx Laboratories, Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Idexx Laboratories's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 59.33%, the Debt to Equity ratio from the most recent quarter is 73.16, and its Gross Profit Margin stands at 62.44%.

What is the recent revenue and earnings growth for IDXX?

Looking at Idexx Laboratories's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.60%, and quarterly earnings saw a YoY growth of 3.00%.

How much of IDXX stock is held by insiders and institutions?

Wondering who owns Idexx Laboratories stock? Company insiders (like executives and directors) hold about 0.67% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.52%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.